Monday, 19 September 2022

Sandoz releases postive trial result of denosumab

Sandoz releases postive trial result of denosumab
Sandoz releases postive trial result of denosumab

Sandoz announces the release of positive results from the integrated ROSALIA Phase 3 clinical trial study for its proposed biosimilar denosumab.

Rajesh Vagh Mon, 09/19/2022 - 13:37

source https://www.pharmatutor.org/pharma-news/2022/sandoz-releases-postive-trial-result-of-denosumab

No comments:

Post a Comment

Pharmaceutical Industry and pharma / Life Sciences institute openings 2025

  Intas Pharma Walk in Drive for M.Pharm, B.Pharm | Multiple Posts M.Pharma / B.Pharma. Injectable/Parenteral/Sterile - Aseptic, Manufacturi...